Navigation Links
Protein regulates enzyme linked to Alzheimer's disease
Date:5/25/2010

BOSTON (May 25, 2010) Researchers at Tufts University School of Medicine have zeroed in on a protein that may play a role in the progression of Alzheimer's disease. The team found that increasing levels of the protein (called GGA3) prevented the accumulation of an enzyme linked to Alzheimer's. The strategy may lead to new treatments for the neurodegenerative disease. The findings were published online May 18 in the Journal of Biological Chemistry.

People with Alzheimer's disease typically have higher levels of an enzyme called BACE1 in their brains. BACE1 produces a toxin that researchers have pinpointed as a cause of Alzheimer's, and now, researchers have found a way to prevent BACE1 from accumulating in the brain.

"We have identified the protein that takes this enzyme to the cell's garbage disposal for removal. Increasing levels of the protein allows more of the enzyme to be eliminated, possibly preventing the high levels seen in people with Alzheimer's disease," said senior author Giuseppina Tesco, MD, PhD, assistant professor in the department of neuroscience at Tufts University School of Medicine (TUSM).

Tesco and colleagues previously discovered that levels of the GGA3 protein were significantly lower in the brains of Alzheimer's patients than those free of the disease. In the current in vitro study, the team also found, unexpectedly, that the GGA3 protein must bind with the regulatory protein ubiquitin in order to lower enzyme levels.

"This insight advances our understanding of the molecular mechanisms of Alzheimer's disease. We hope that our approach will lead to new therapies that treat and prevent Alzheimer's, which currently affects as many as 5.1 million Americans," said Tesco. Tesco is also a member of the neuroscience program faculty at the Sackler School of Graduate Biomedical Sciences at Tufts, leading the Alzheimer's disease research laboratory.

Alzheimer's disease is a progressive neurodegenerative disorder that results in loss of memory and cognitive function. It is the most common cause of dementia in adults age 65 and over. Currently, prescription drugs are available that may slow the progression of the disease, but none of these medications are effective in stopping the progression of Alzheimer's.


'/>"/>

Contact: Siobhan Gallagher
617-636-6586
Tufts University, Health Sciences
Source:Eurekalert

Related biology news :

1. Intracellular express -- why transport protein molecules have brakes
2. Protein power for Jack and the beanstalk
3. Study finds protein that plays key role in early embryonic development
4. Jefferson scientists identify a new protein involved in longevity
5. Dietary protein may reduce hip fractures in the elderly
6. Glaucomas unique protein expression could enhance diagnosis and treatment
7. AAPS presents therapeutic protein drug interactions workshop
8. Synthetic enzymes could help ID proteins
9. New data on the regulation of a protein that is altered in all cancers
10. Research pinpoints action of protein linked to key molecular switch
11. Hopkins researchers put proteins right where they want them
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/28/2016)... India , April 28, 2016 ... Infosys (NYSE: INFY ), and Samsung SDS, a ... that will provide end customers with a more secure, ... services.      (Logo: http://photos.prnewswire.com/prnh/20130122/589162 ) , ... services, but it also plays a fundamental part in enabling ...
(Date:4/26/2016)... 2016 Research and Markets has ... Market 2016-2020"  report to their offering.  , ,     ... The analysts forecast the global multimodal biometrics market ... the period 2016-2020.  Multimodal biometrics is ... as the healthcare, BFSI, transportation, automotive, and government ...
(Date:4/15/2016)... 15, 2016 Research and ... Biometrics Market 2016-2020,"  report to their offering.  , ... , ,The global gait biometrics market is expected ... the period 2016-2020. Gait analysis generates ... be used to compute factors that are not ...
Breaking Biology News(10 mins):
(Date:6/27/2016)... 27, 2016   Ginkgo Bioworks , a leading ... was today awarded as one of the World ... world,s most innovative companies. Ginkgo Bioworks is engineering ... real world in the nutrition, health and consumer ... with customers including Fortune 500 companies to design ...
(Date:6/24/2016)... ... ... Researchers at the Universita Politecnica delle Marche in Ancona combed medical journal ... Their findings are the subject of a new article on the Surviving Mesothelioma website. ... the blood, lung fluid or tissue of mesothelioma patients that can help point doctors ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
(Date:6/23/2016)... SANTA MONICA, Calif. , June 23, 2016  The Prostate Cancer ... to pioneer increasingly precise treatments and faster cures for prostate cancer. Members of ... 77 institutions across 15 countries. Read More About the ... ... ...
Breaking Biology Technology: